Limited Market Adoption and Intense Competition: The company operates in a market with established manual methods and competing automated solutions, and failure to achieve broad market acceptance for its automated microbial detection systems could negatively impact financial performance.

Regulatory Compliance and Approval Processes: Rapid Micro Biosystems' products and operations are subject to extensive and complex regulations, particularly from the FDA and similar international bodies, and any failure to comply or obtain necessary approvals could lead to product delays, recalls, or penalties.

Dependence on Key Customers and Strategic Alliances: A significant portion of the company's revenue may depend on a limited number of pharmaceutical and medical device customers, and the loss of any major customer or failure of strategic partnerships could materially harm its business.